Permission for Martini Hospital to use a wider range of radioactive materials
Martini Hospital in Groningen has received permission to use a wider range of radioactive materials in its treatment of patients with cardiovascular, thyroid and prostate conditions. The ANVS has agreed to the expansion of the hospital’s existing licence. Interested parties have the right to appeal against our decision until midnight on 9 April.
Three reasons to grant an expanded licence
We have agreed to an expansion of the hospital’s licence for three reasons:
- first, the hospital takes sufficient measures to protect workers, patients and the environment from radiation;
- second, the hospital has a sufficient number of specialists in-house to handle radiation safely;
- third, patient care will improve.
Reducing the need for hospitalisation
Martini Hospital is a major specialised teaching hospital in Groningen. The hospital will now receive a licence to use a wider range of radioactive materials. The medical use of radioactive materials helps doctors identify the nature of a problem with a patient’s heart, for example. They can also be used to treat an overactive thyroid.
Doctors will now also be permitted to administer higher doses of these materials. These changes would enable doctors to treat patients on an outpatient basis, thereby reducing the need for hospitalisation. A relatively new application is geared towards helping patients who suffer from prostate problems.
Appeals possible until 9 April 2025
If you are an interested party and you are directly affected by our decision to grant this licence, then you have the right to appeal (in Dutch) against the licensing decision (in Dutch) until 9 April 2025. You can also lodge an appeal if your failure to submit a statement of opinion before cannot reasonably be held against you. The deadline for submitting a statement of opinion passed on 1 January 2025, without us receiving any responses of this kind.
Would you like to find out more?
Please read the official announcement (in Dutch) in the Government Gazette. Or go to our website if you would like to find out more about our monitoring of nuclear medicine (in Dutch).